Disclosed positions

Estimated from their latest filings — positions may have changed since

$283.3K

combined est. value

Stock	Shares	Price	Value	Weight	As of
LYELLyell Immunopharma, Inc.	17,808	$15.91	$283.3K	100%	2026-05-11

LYEL

Lyell Immunopharma, Inc.

$283.3K

17,808 sh

All filings on record

Every Form 4 transaction we track for this filer

all 9buys 0sells 7

Stock	Transaction	Date	~6mo later
LYELLyell Immunopharma, Inc.	Sell $2.5K · 130 sh	2026-05-11	—
LYELLyell Immunopharma, Inc.	Sell $39.1K · 1,671 sh	2026-02-11	—
LYELLyell Immunopharma, Inc.	Sell $3.4K · 147 sh	2026-02-10	—
LYELLyell Immunopharma, Inc.	Grant — · 4,000 sh	2026-02-09	—
LYELLyell Immunopharma, Inc.	Sell $2.2K · 138 sh	2025-11-10	—
LYELLyell Immunopharma, Inc.	Sell $15.3K · 1,453 sh	2025-08-21	—
LYELLyell Immunopharma, Inc.	Grant — · 8,000 sh	2025-08-20	—
LYELLyell Immunopharma, Inc.	Sell $1.4K · 136 sh	2025-08-12	—
LYELLyell Immunopharma, Inc.	Sell $1.4K · 131 sh	2025-08-11	—

LYELSell

2026-05-11 · Lyell Immunopharma, Inc.

$2.5K

—

LYELSell

2026-02-11 · Lyell Immunopharma, Inc.

$39.1K

—

LYELSell

2026-02-10 · Lyell Immunopharma, Inc.

$3.4K

—

LYELGrant

2026-02-09 · Lyell Immunopharma, Inc.

4,000

—

LYELSell

2025-11-10 · Lyell Immunopharma, Inc.

$2.2K

—

LYELSell

2025-08-21 · Lyell Immunopharma, Inc.

$15.3K

—

LYELGrant

2025-08-20 · Lyell Immunopharma, Inc.

8,000

—

LYELSell

2025-08-12 · Lyell Immunopharma, Inc.

$1.4K

—

LYELSell

2025-08-11 · Lyell Immunopharma, Inc.

$1.4K

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.